Table 5. Clinical features, postoperative complications and adjuvant treatment as related to the development of lymphedema after 30 months of follow-up.
| Lymphedema | p-value | ||||
|---|---|---|---|---|---|
| Yes | No | ||||
| N | % | n | % | ||
| Groups | 0.3980 | ||||
| AE | 11 | 30.6 | 25 | 69.4 | |
| MLD | 9 | 28.1 | 23 | 71.9 | |
| Age | 20 | 55.1±17.5 | 48 | 59.2±13.0 | 0.4001 |
| BMI (kg/m2) | 20 | 28.07±5.96 | 48 | 28.37±5.96 | 0.7066 |
| Seroma | 0.4827 | ||||
| Yes | 6 | 33.3 | 19 | 40.4 | |
| No | 12 | 66.7 | 28 | 59.6 | |
| Dehiscence | 0.9126* | ||||
| Yes | 3 | 16.7 | 6 | 12.8 | |
| No | 15 | 83.3 | 41 | 87.2 | |
| Infection | 0.2047 | ||||
| Yes | 6 | 33.3 | 13 | 27.7 | |
| No | 12 | 66.7 | 34 | 72.3 | |
| Neoadjuvant chemotherapy | 0.5944 | ||||
| Yes | 15 | 75.0 | 25 | 52.1 | |
| No | 5 | 25.0 | 23 | 47.9 | |
| Adjuvant chemotherapy | 0.9419 | ||||
| Yes | 16 | 80.0 | 25 | 54.3 | |
| No | 4 | 20.0 | 21 | 45.7 | |
| Radiotherapy | 0.9440 | ||||
| Yes | 14 | 82.4 | 35 | 76.1 | |
| No | 3 | 17.6 | 11 | 23.9 | |
Chi-Square test;
(*) Fisher’s Exact test;
SCF = supraclavicular fossa; SD = standard deviation